Clinical evaluation reveals bone mineral density as a prognostic marker in biliary tract cancer surgery, highlighting preoperative risk stratification.
Biliary tract cancer (BTC) is one of the most aggressive malignancies and surgery represents the only curative treatment approach. However, even in patients with complete tumor resection 5-year survival rates are below 30%. So far, prognostic markers to assess the outcome of these patients are lacking. We therefore evaluated bone mineral density (BMD) as a prognostic tool in patients receiving surgery for BTC.
No takes yet. Share an insight, caveat, or question.
Heinrichs et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: